cancer-bg.png
Package
Early-Stage Cancer Cell Detection 10 Types
Detecting cancer cell genetic markers released into the bloodstream (ctDNA) using Next-Generation Sequencing technology.
cancer-icon-1.png
cancer-bg-2.png
Why Does "Early-Stage Cancer Detection"
Matter So Much?
Cancer remains one of the leading causes of death in Thailand and worldwide. The WHO projects that by 2030, cancer mortality rates will rise by more than 45%. What's alarming is that over 70% of patients are diagnosed at a late stage, making treatment difficult and survival rates low.

Meanwhile... when detected at an early stage, the survival rate can reach as high as 90–95%.
cancer-icon-2.png

 

724-(1).jpg
Cancer cases in
Thailand grow yearly
On average, 381 new Thai cancer
cases are diagnosed per day*
Group-59-(2).png
*2022 data from the National Health Security Office (NHSO)
https://www.nhso.go.th/news/3893
Comparing
Survival Rate Data*
Early detection may help patients
access treatment sooner
Group-59-(3).png
*5-year survival rates: Incidence and relative survival rates by
stage for common cancers. USCS Data Brief No. 25,
Atlanta: CDC, U.S. Department of Health and Human Services

 

 

cancer-bg-6.png
Specificity
99.8%
Sensitivity
78.1%
cancer-bg-4.png
Early Detection May Help Improve Treatment Outcomes
Detect Early. Know Early. Stay Safer. With Next-Generation Sequencing (NGS) technology, we can detect cancer cell DNA fragments (ctDNA) circulating in the bloodstream.
  • Detects multiple genetic mutations simultaneously
  • Identifies risk even in individuals with no symptoms
This is a significant step forward in early-stage cancer screening, empowering you to plan your life with greater confidence.
cancer-icon-4.png

 

729.jpg
Multi-Cancer Early Detection
(10 Types)
Union.png
Breast Cancer
Vector.png
Lung Cancer
Vector-(1).png
Colorectal Cancer
Vector-(2).png
Gastric
Cancer
Union-(1).png
Liver and
Bile Duct Cancer
Vector-(3).png
Uterine
Cancer
Union-(2).png
Esophageal
Cancer
Vector-(4).png
Ovarian Cancer
Union-(3).png
Pancreatic Cancer
Union-(4).png
Head and
Neck Cancer
734.jpg
01
Isolate cfDNA (cell-free DNA) and prepare genetic libraries from a single blood sample.
Group-49-(1).png
 
02
Perform both Targeted and Genome-wide sequencing to capture multi-omic data (Multi-omics) and cfDNA fragment sizes.
Group-02-test.png
 
03
Advanced analysis and selection of features from multi-omic data (Multi-omic Features).
Group-03-test.png
 
04
Apply Machine Learning and Deep Learning models to classify cfDNA signals from cancer patients and identify the tissue of origin of the cancer.
Group-04-test.png
cancer-bg-10.png
Who Should Get Tested?
health-icon-10-1.png
Individuals aged 40 and above, due to increased risk of various cancers (even without any symptoms)
cancer-icon-10-1.png
Anyone seeking cancer screening, or those with a family history of cancer
cancer-icon-10-2.png
Individuals with high-risk behaviors such as smoking, alcohol consumption, exposure to carcinogens, or living in areas with high PM2.5 pollution

 

cancer-bg-11.png
Warning Signs and Symptoms
Suggestive of Cancer
Anyone with any of the following signs should see a doctor immediately instead of undergoing screening.
  • Unexplained weight loss of more than 6 kg within 6 months
  • Persistent cough lasting more than 3 weeks that does not respond to medication
  • Prolonged abdominal pain in the right rib area or epigastric region that does not respond to medication
  • Abnormal bleeding, unusual lumps in the body, or nipple discharge
cancer-bg-12.png
Preparation Before Your Visit and Health Screening Recommendations
ic-clock.png
Fast from food and drinks
8–10 hours (plain water is allowed)
ic-wine.png
Avoid alcohol
24 hours
ic-bed.png
Get sufficient sleep
At least 6 hours
health-icon-11-5.png
Await test results
30 days
-(2).png
Please make an appointment in advance
before your visit
  • (If applicable) Please inform us of your medical history and any pre-existing conditions before your visit.

 

Multi-Cancer Early Detection (10 Types)
Screens for 10 cancer types at once with a single blood draw with no surgery and no biopsy required.
Uses Next-Generation Sequencing technology to analyze circulating tumor DNA (ctDNA) released into the bloodstream.
High accuracy with 99.8% specificity and 78.1% sensitivity.
Results available within 30 days.
Price 20,600 THB
16,460
THB
Book Now

Multi-Cancer Early Detection Package (10 Types)

Detect early. Prevent more. Our Multi-Cancer Early Detection technology screens for 10 types of cancer at their earliest stage. A breakthrough in proactive healthcare powered by Next-Generation Sequencing (NGS), which analyzes cancer cell DNA in the bloodstream (Circulating Tumor DNA: ctDNA). A single blood draw is all it takes to screen for up to 10 cancers simultaneously, even if you are not in a high-risk group.

b1.png
Multi-Cancer Early Detection
Technology
b2.png
Convenient, Safe, Minimally Invasive
and Highly Accurate
b3.png
Suitable for Ages
18 and Above
b4.png
Results Ready within 30 Days
 

A new choice for a longer, safer life. Because knowing early... is the best chance of survival.
For more information or to book a free consultation, contact us today!

 

Cancer Stroke
Recommended